NM_022840.5:c.548A>G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022840.5(METTL4):c.548A>G(p.Asp183Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000681 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022840.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| METTL4 | ENST00000574538.2 | c.548A>G | p.Asp183Gly | missense_variant | Exon 4 of 9 | 1 | NM_022840.5 | ENSP00000458290.1 | ||
| METTL4 | ENST00000573134.1 | n.945A>G | non_coding_transcript_exon_variant | Exon 3 of 7 | 1 | |||||
| METTL4 | ENST00000319888.10 | c.548A>G | p.Asp183Gly | missense_variant | Exon 4 of 8 | 5 | ENSP00000320349.6 | |||
| METTL4 | ENST00000577166.5 | c.107A>G | p.Asp36Gly | missense_variant | Exon 4 of 4 | 4 | ENSP00000458415.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251354 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461774Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727186 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74502 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.548A>G (p.D183G) alteration is located in exon 4 (coding exon 3) of the METTL4 gene. This alteration results from a A to G substitution at nucleotide position 548, causing the aspartic acid (D) at amino acid position 183 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at